Influenza Testing and Treatment Guidelines

Testing Recommendations

The Infectious Diseases Society of America recommends testing for influenza in high-risk patients, including immunocompromised persons, who present with influenza-like illness, pneumonia, or nonspecific respiratory illness if testing will influence clinical management 1, 2
The Infectious Diseases Society of America recommends testing patients with acute respiratory symptoms with/without fever who have exacerbation of chronic medical conditions or known complications of influenza 1, 2
The American Academy of Pediatrics suggests that rapid antigen tests have lower sensitivity (10-80%) compared to molecular methods (86-100%) 3, 4
Negative results from rapid antigen tests should not be used to rule out influenza due to potential false-negatives, especially when clinical suspicion is high, as stated by the American Academy of Pediatrics 3, 4

The American Academy of Pediatrics recommends that PCR confirmation should be considered in hospitalized patients 3, 4
Rapid antigen tests are most sensitive when performed within the first 48 hours of symptom onset, according to the Infectious Diseases Society of America 1

The American Academy of Pediatrics recommends that antiviral treatment should be started as soon as possible after illness onset and should not be delayed while waiting for test results 3, 4

The Infectious Diseases Society of America advises against waiting for test results before initiating treatment in high-risk patients 3, 4
The Journal of Infection suggests that full blood count, urea and electrolytes, liver function tests, and chest X-ray should be performed in all hospitalized patients 5, 6
Pulse oximetry should be performed in all patients, with arterial blood gases if oxygen saturation is <92% on air, as recommended by the Journal of Infection 5, 6

Rapid influenza diagnostic tests (RIDTs) have high specificity (>90%) but low to moderate sensitivity (10-80%), making false negative results common 7, 8, 9
Sensitivity varies by test type, with molecular assays (86-100% sensitivity) being more accurate than antigen detection methods 8, 10
False negative results are more likely when viral shedding is lower (more common in adults than children) 11
Improper specimen collection or handling can also lead to false negative results 10

Consider local influenza activity - higher prevalence increases the likelihood that a negative test is false 12, 9
For hospitalized patients or those with severe illness, confirm negative rapid test results with more sensitive methods such as PCR 7, 8
PCR testing is the gold standard with sensitivity of 86-100% 8, 10

Initiate antiviral treatment immediately without waiting for confirmatory test results in high-risk patients 8, 10
Start empiric antiviral treatment regardless of rapid test results in hospitalized patients 13, 10
Complete the full antiviral treatment course regardless of negative initial test results unless an alternative diagnosis is established 13

Oseltamivir (oral) is the preferred first-line agent for most patients 10
Alternative options include zanamivir (inhaled), peramivir (IV), or baloxavir (oral) based on patient factors and availability 10

Do not use negative rapid test results to rule out influenza when clinical suspicion is high 7, 8
Do not delay antiviral treatment while awaiting confirmatory test results in high-risk patients 10